| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Zakaria Zakariaei, Shervin Taslimi, Mohammad Amin Tabatabaiefar, Mosa Arghand Dargah. Bilateral dislocation of temporomandibular joint induced by haloperidol following suicide attempt: a case report. Acta medica Iranica. vol 50. issue 3. 2012-07-12. PMID:22418992. |
haloperidol, as a high potent typical antipsychotic drug, can induce dystonia with blocking d2 dopamine receptors. |
2012-07-12 |
2023-08-12 |
Not clear |
| Flávia Regina Cruz Dias, Liana Wermelinger de Matos, Maria de Fátima dos Santos Sampaio, Robert J Carey, Marinete Pinheiro Carrer. Opposite effects of low versus high dose haloperidol treatments on spontaneous and apomorphine induced motor behavior: evidence that at a very low dose haloperidol acts as an indirect dopamine agonist. Behavioural brain research. vol 229. issue 1. 2012-06-26. PMID:22244923. |
opposite effects of low versus high dose haloperidol treatments on spontaneous and apomorphine induced motor behavior: evidence that at a very low dose haloperidol acts as an indirect dopamine agonist. |
2012-06-26 |
2023-08-12 |
rat |
| Flávia Regina Cruz Dias, Liana Wermelinger de Matos, Maria de Fátima dos Santos Sampaio, Robert J Carey, Marinete Pinheiro Carrer. Opposite effects of low versus high dose haloperidol treatments on spontaneous and apomorphine induced motor behavior: evidence that at a very low dose haloperidol acts as an indirect dopamine agonist. Behavioural brain research. vol 229. issue 1. 2012-06-26. PMID:22244923. |
two new key findings are (a) that a low dose haloperidol regimen can function as a dopamine agonist and these effects persist after withdrawal and (b) that repeated apomorphine treatments can desensitize d2 receptors previously sensitized by a high dose haloperidol treatment regimen. |
2012-06-26 |
2023-08-12 |
rat |
| Sung Woo Park, Mi Kyoung Seo, Hye Yeon Cho, Jung Goo Lee, Bong Ju Lee, Wongi Seol, Young Hoon Ki. Differential effects of amisulpride and haloperidol on dopamine D2 receptor-mediated signaling in SH-SY5Y cells. Neuropharmacology. vol 61. issue 4. 2012-05-25. PMID:21663752. |
differential effects of amisulpride and haloperidol on dopamine d2 receptor-mediated signaling in sh-sy5y cells. |
2012-05-25 |
2023-08-12 |
Not clear |
| E Iu Parnyshkova, V P Lavrovskaia, E N Bezgina, L L Pavlik, E I Lezhnev, D A Moshko. [Morphological bases of dopamine effect on HEP-2 tumor cells viability]. Morfologiia (Saint Petersburg, Russia). vol 140. issue 6. 2012-05-09. PMID:22506356. |
this was indicated by fluorescent microscopical evidence of dopamine penetration into experimental cells in the presence of haloperidol, as well as destruction of hep-2 cells under the action of pyrimidinethione, similar to dopamine by characteristics, but lacking its own receptors. |
2012-05-09 |
2023-08-12 |
Not clear |
| Mariano Soiza-Reilly, Julio M Azcurr. Activity-dependent reduction of dopamine D2 receptors during a postnatal critical period of plasticity in rat striatum is not affected by prenatal haloperidol treatment. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience. vol 29. issue 8. 2012-04-23. PMID:21856408. |
activity-dependent reduction of dopamine d2 receptors during a postnatal critical period of plasticity in rat striatum is not affected by prenatal haloperidol treatment. |
2012-04-23 |
2023-08-12 |
rat |
| Jason P Capla. Delirium, sigma-1 receptors, dopamine, and glutamate: how does haloperidol keep the genie in the bottle?*. Critical care medicine. vol 40. issue 3. 2012-04-23. PMID:22343842. |
delirium, sigma-1 receptors, dopamine, and glutamate: how does haloperidol keep the genie in the bottle? |
2012-04-23 |
2023-08-12 |
Not clear |
| Johan P Rung, Emilia Rung, Anette M Johansson, Kjell Svensson, Arvid Carlsson, Maria L Carlsso. Effects of the dopamine stabilizers (S)-(-)-OSU6162 and ACR16 on prolactin secretion in drug-naive and monoamine-depleted rats. Naunyn-Schmiedeberg's archives of pharmacology. vol 384. issue 1. 2012-04-16. PMID:21533991. |
both compounds show a non-significant trend towards reversal of the increased secretion caused by dopamine depletion, whereas the d2 receptor antagonist haloperidol further increased prolactin secretion. |
2012-04-16 |
2023-08-12 |
rat |
| Violeta Medan, Thomas Preus. Dopaminergic-induced changes in Mauthner cell excitability disrupt prepulse inhibition in the startle circuit of goldfish. Journal of neurophysiology. vol 106. issue 6. 2012-04-16. PMID:21957221. |
consistently, application of the dopamine antagonist haloperidol (0.4 mg/kg body wt) restored ppi to control level. |
2012-04-16 |
2023-08-12 |
Not clear |
| Richard J Wix-Ramos, Reinalis Paez, Eduardo Capote, Uribe Ezequie. Pituitary microadenoma treated with antipsychotic drug aripiprazole. Recent patents on endocrine, metabolic & immune drug discovery. vol 5. issue 1. 2012-04-06. PMID:22074578. |
we also consider the correlation of drug use in patient with psychosis, haloperidol treatment, pituitary microadenoma syndrome, hyperprolactinemia, and dopamine d2- receptor partial agonist aripiprazole treatment. |
2012-04-06 |
2023-08-12 |
Not clear |
| Raquel Levin, Mariana Bendlin Calzavara, Camila Maurício Santos, Wladimir Agostini Medrano, Suzy Tamie Niigaki, Vanessa Costhek Abíli. Spontaneously Hypertensive Rats (SHR) present deficits in prepulse inhibition of startle specifically reverted by clozapine. Progress in neuro-psychopharmacology & biological psychiatry. vol 35. issue 7. 2012-02-08. PMID:21693159. |
pharmacological characterization consisted in the evaluation of the effects of the following drugs administered to adult wistar rats (wr) and shr previously to the ppi test: amphetamine (used for adhd and also a psychotomimetic drug), haloperidol and clozapine (antipsychotic drugs), metoclopramide (dopamine antagonist without antipsychotic properties) and carbamazepine (mood stabilizer). |
2012-02-08 |
2023-08-12 |
rat |
| H Kamiyama, M Matsumoto, S Otani, S-I Kimura, K-I Shimamura, S Ishikawa, Y Yanagawa, H Togash. Mechanisms underlying ketamine-induced synaptic depression in rat hippocampus-medial prefrontal cortex pathway. Neuroscience. vol 177. 2012-01-19. PMID:21163337. |
but not dopamine d2 receptor antagonist haloperidol (1.5 mg/kg, i.p. |
2012-01-19 |
2023-08-12 |
rat |
| Patrícia Nardin, Ana Carolina Tramontina, André Quincozes-Santos, Lucas S Tortorelli, Paula Lunardi, Paulo R Klein, Krista M Wartchow, Larissa D Bobermin, Carmem Gottfried, Elaine Elisabetsky, Carlos-Alberto Gonçalve. In vitro S100B secretion is reduced by apomorphine: effects of antipsychotics and antioxidants. Progress in neuro-psychopharmacology & biological psychiatry. vol 35. issue 5. 2012-01-19. PMID:21513766. |
we investigated s100b secretion in three different rat brain preparations (fresh hippocampal slices, c6 glioma cells and primary astrocyte cultures) exposed to apomorphine and antipsychotics (haloperidol and risperidone), aiming to evaluate, ex vivo and in vitro, whether dopamine activation and dopaminergic antagonists modulate astroglial activation, as measured by changes in the extracellular levels of s100b. |
2012-01-19 |
2023-08-12 |
rat |
| C K Young, I Q Whishaw, B H Blan. Posterior hypothalamic nucleus deep brain stimulation restores locomotion in rats with haloperidol-induced akinesia but not skilled forelimb use in pellet reaching and lever pressing. Neuroscience. vol 192. 2012-01-18. PMID:21723925. |
recent studies have shown that electrical stimulation of the posterior hypothalamic nucleus (ph) facilitates locomotion in control rats, and rats were made akinetic by dopaminergic blockade via haloperidol or dopamine depletion by the neurotoxin 6-hydroxydopamine. |
2012-01-18 |
2023-08-12 |
rat |
| Mahendra Bishnoi, Kanwaljit Chopra, Lu Rongzhu, Shrinivas K Kulkarn. Protective effect of curcumin and its combination with piperine (bioavailability enhancer) against haloperidol-associated neurotoxicity: cellular and neurochemical evidence. Neurotoxicity research. vol 20. issue 3. 2011-11-29. PMID:21076901. |
neurochemically, chronic administration of haloperidol resulted in a significant decrease in the levels of norepinephrine, dopamine, and serotonin. |
2011-11-29 |
2023-08-12 |
rat |
| Morten V Madsen, Linda P Peacock, Thomas Werge, Maibritt B Andersen, Jesper T Andrease. Effects of cannabinoid CB1 receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys. Neuropharmacology. vol 60. issue 2-3. 2011-11-22. PMID:21029743. |
the present study explored the effects of cb(1) receptor ligands on oral dyskinesia induced by the dopamine d(1) receptor agonist skf81297 (skf) and acute dystonia induced by the dopamine d(2) receptor antagonist haloperidol in cebus apella monkeys. |
2011-11-22 |
2023-08-12 |
rat |
| Samuel D Banister, Iman A Moussa, William T Jorgensen, Sook Wern Chua, Michael Kassio. Molecular hybridization of 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecane-3-ol with sigma (σ) receptor ligands modulates off-target activity and subtype selectivity. Bioorganic & medicinal chemistry letters. vol 21. issue 12. 2011-11-22. PMID:21555222. |
the molecular hybrid obtained from haloperidol and 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ol (4, σ(1)k(i)=27 nm, σ(2)k(i)=55 nm) showed reduced affinity for d(1)-d(5) dopamine receptors when compared to haloperidol itself. |
2011-11-22 |
2023-08-12 |
Not clear |
| Yui Yamamoto, Norifumi Shioda, Yuji Owada, Kohji Fukunag. [Regulation of dopaminergic neuronal activity by heart-type fatty acid binding protein in the brain]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. vol 131. issue 4. 2011-11-15. PMID:21467787. |
haloperidol as a potent dopamine d2 receptor (d2r) antagonist was a major tranquilizer to treat schizophrenia patients. |
2011-11-15 |
2023-08-12 |
mouse |
| Omar M E Abdel-Sala. Modulation of visceral nociception, inflammation and gastric mucosal injury by cinnarizine. Drug target insights. vol 2. 2011-10-26. PMID:21901060. |
this effect of cinnarizine (2.5 mg/kg) was unaffected by co-administration of the centrally acting dopamine d2 receptor antagonists, sulpiride, haloperidol or metoclopramide, the peripherally acting d2 receptor antagonist domperidone, but increased by the d2 receptor agonist bromocryptine and by the non-selective dopamine receptor antagonist chlorpromazine. |
2011-10-26 |
2023-08-12 |
rat |
| Christal Sookram, Mattea Tan, Ritesh Daya, Spencer Heffernan, Ram K Mishr. Curcumin prevents haloperidol-induced development of abnormal oro-facial movements: possible implications of Bcl-XL in its mechanism of action. Synapse (New York, N.Y.). vol 65. issue 8. 2011-10-18. PMID:21218454. |
however, it is unclear whether short term curcumin administration can prevent the abnormal oro-facial movements (aofm) which develop following blockade of dopamine d2 receptors by antagonist such as haloperidol. |
2011-10-18 |
2023-08-12 |
rat |